Pharmaceutical formulation patents are important for pharmaceutical companies, as the scope of protection for formulation patents is usually very close to or covers the composition and content of the actual marketed drugs. From the perspective of extending the protec...

On December 17, 2024, the China National Intellectual Property Administration announced that "Xinjiang Huachun Biological Pharmaceutical Co., Ltd." (hereinafter referred to as "Huachun Pharmaceutical") was approved to extend its core patent ZL03156365.1 (hereinafter ...